ICON8 Trial: Impact on Clinical Practice with Jonathan Ledermann

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Jonathan Ledermann to talk about the ICON8 Trial and its impact on clinical practice. Dr. Ledermann is a professor of medical oncology at UCL Cancer Institute specializing in the treatment and research of gynecological malignancies. He has been the Director of the Cancer Research UK and UCL Cancer Trials Centre for over 20 years and has led several national and international trials on the treatment of ovarian cancer. He has had a key role in developing trials of PARP inhibitors in ovarian cancer. Dr. Ledermann is a Fellow of the Academy of Medical Sciences and Senior Investigator for the National Institute of Health Research in the UK.